Geron
GERN
#6280
Rank
NZ$1.44 B
Marketcap
NZ$2.27
Share price
3.15%
Change (1 day)
-66.49%
Change (1 year)

Geron (GERN) - Cash on Hand

Cash on Hand as of September 2025 : NZ$0.65 Billion

According to Geron's latest financial reports the company has NZ$0.65 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Geron - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$0.72 B36.62%
2023-12-31NZ$0.52 B93.94%
2022-12-31NZ$0.27 B1.16%
2021-12-31NZ$0.26 B-1.12%
2020-12-31NZ$0.27 B31.49%
2019-12-31NZ$0.20 B-15.02%
2018-12-31NZ$0.24 B82.59%
2017-12-31NZ$0.13 B-19.59%
2016-12-31NZ$0.16 B-0.26%
2015-12-31NZ$0.16 B-14%
2014-12-31NZ$0.19 B143.52%
2013-12-31NZ$79.37 M-31.65%
2012-12-31NZ$0.11 B-25.29%
2011-12-31NZ$0.15 B-35.73%
2010-12-31NZ$0.24 B57.38%
2009-12-31NZ$0.15 B-45.24%
2008-12-31NZ$0.28 B4.34%
2007-12-31NZ$0.26 B-11.19%
2006-12-31NZ$0.30 B8.66%
2005-12-31NZ$0.27 B65.76%
2004-12-31NZ$0.16 B0.03%
2003-12-31NZ$0.16 B87.19%
2002-12-31NZ$89.78 M-45.92%
2001-12-31NZ$0.16 B122.79%
2000-12-31NZ$74.52 M-0.9%
1999-12-31NZ$75.2 M141.65%
1998-12-31NZ$31.11 M340.46%
1997-12-31NZ$7.06 M-59.74%
1996-12-31NZ$17.55 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Eterna Therapeutics
ERNA
NZ$5.27 M-99.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$12.72 B 1,831.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$0.25 B-61.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
NZ$5.07 B 669.93%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
NZ$0.10 B-84.49%๐Ÿ‡บ๐Ÿ‡ธ USA